Guidelines Issued for Managing Eosinophilic Esophagitis
Topical glucocorticosteroids recommended over no treatment.
Topical glucocorticosteroids recommended over no treatment.
There has been a lot of recent developments in possible COVID-19 treatments. We cover the latest status with remdesivir, hydroxychloroquine, sarilumab, and remestemcel-L, and also the treatment guidelines for COVID-19 issued by the National Institute of Health.
Recommendations on the management of coronavirus disease 2019 (COVID-19) were recently released by the National Institutes of Health (NIH) to help guide clinicians caring for patients with COVID-19.
Guidelines balance competing interests of providing timely, high-quality care with protecting rescuers.
A panel of 9 members from various disciplines in the field of infectious diseases used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) method to develop 7 recommendations for the treatment of patients with COVID-19.
Evidence inconsistent with in utero transmission of SARS-CoV-2 from moms with COVID-19 to neonates
Hydroxychloroquine, chloroquine suggested for hospitalized patients with COVID-19, severe pneumonia.
In order to provide national guidance addressing issues surrounding pain management practices, an expert panel was convened to provide a framework for pain practitioners and institutions.
Fifty-four statements issued on infection control, diagnosis, hemodynamic support, ventilator support, therapy.
Guidance also provided for removal techniques for colorectal lesions of different sizes.